Clinical trial
Acamprosate vs. Placebo in Bipolar Alcoholics
NCT00466661 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00466661 |
|---|---|
| Title | Acamprosate vs. Placebo in Bipolar Alcoholics |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Trial of Acamprosate in Alcohol-Dependent Individuals With Comorbid Bipolar Disorder |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcohol Dependence, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Acamprosate, Placebo |
| Enrollment | 33 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Apr 27, 2007 |
| Last update posted | Dec 14, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: